Linked Life Data

16931455

Source:http://linkedlifedata.com/resource/pubmed/id/16931455

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-8-25
pubmed:abstractText
The concept that inflammation plays a major role in atherogenesis has become accepted in recent years (Hansson 2005). As a result, anti-inflammatory agents may become increasingly important in the treatment of atherogenesis, atherosclerosis, and possibly even acute coronary or ischemic syndromes. This presentation reviews two types of molecules associated with the diagnosis, development, or treatment of atherosclerosis: C-reactive protein (CRP), and cannabis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1381-3455
pubmed:author
pubmed:issnType
Print
pubmed:volume
112
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
130-7
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
New anti-inflammatory agents to reduce atherosclerosis.
pubmed:affiliation
Cardiology Division, Geneva University Hospital, Geneva, Switzerland. Francois.Mach@medecine.unige.ch
pubmed:publicationType
Journal Article, Review